Evidence map›Paper›PMID 27906995›Full record

ArticlePloS one2016

Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.

Nicholus Mutenda, Alexandra Bukowski, Anne-Marie Nitschke, Tuli Nakanyala, Ndapewa Hamunime, Tadesse Mekonen, Francina Tjituka, Greatjoy Mazibuko, Samson Mwinga, David Mabirizi and 5 more

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nicholus MutendaDirectorate of Special Programmes, Republic of Namibia Ministry of Health and Social Services, Windhoek, Namibia.
Alexandra BukowskiDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
Anne-Marie NitschkeDirectorate of Special Programmes, Republic of Namibia Ministry of Health and Social Services, Windhoek, Namibia.
Tuli NakanyalaDirectorate of Special Programmes, Republic of Namibia Ministry of Health and Social Services, Windhoek, Namibia.
Ndapewa HamunimeDirectorate of Special Programmes, Republic of Namibia Ministry of Health and Social Services, Windhoek, Namibia.
Tadesse MekonenDirectorate of Special Programmes, Republic of Namibia Ministry of Health and Social Services, Windhoek, Namibia.
Francina TjitukaDirectorate of Special Programmes, Republic of Namibia Ministry of Health and Social Services, Windhoek, Namibia.
Greatjoy MazibukoSystems for Improved Access to Pharmaceuticals and Services (SIAPS), Management Sciences for Health, Windhoek, Namibia.
Samson MwingaSystems for Improved Access to Pharmaceuticals and Services (SIAPS), Management Sciences for Health, Windhoek, Namibia.
David MabiriziSystems for Improved Access to Pharmaceuticals and Services (SIAPS), Management Sciences for Health, Windhoek, Namibia.
Evans SagwaSystems for Improved Access to Pharmaceuticals and Services (SIAPS), Management Sciences for Health, Windhoek, Namibia.
Rosalia IndongoUnited States Agency for International Development, Windhoek, Namibia.
Natalie DeanDepartment of Biostatistics, University of Florida, Gainesville, Florida, United States of America.
Michael R JordanDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
Steven Y HongDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe World Health Organization (WHO) early warning indicators (EWIs) of HIV drug resistance (HIVDR) assess factors at individual ART sites that are known to create situations favourable to the emergence of HIVDR.

methodsIn 2014, the Namibia HIV care and treatment program abstracted the following adult and pediatric EWIs from all public ART sites (50 main sites and 143 outreach sites): On-time pill pick-up, Retention in care, Pharmacy stock-outs, Dispensing practices, and Viral load suppression. Comparisons were made between main and outreach sites and between 2014 and 2012 using the Wilcoxon signed-rank test in a matched analysis.

resultsThe national estimates were: On-time pill pick-up 81.9% (95% CI 81.1-82.8) for adults and 82.4% (81.3-83.4) for pediatrics, Retention in care 79% retained on ART after 12 months for adults and 82% for pediatrics, Pharmacy stock-outs 94% of months without a stock-out for adults and 88% for pediatrics, and Dispensing practices 0.01% (0.001-0.056) dispensed mono- or dual-therapy for adults and 0.01% (0.001-0.069) for pediatrics. Viral load suppression was significantly affected by low rates of Viral load completion. Main sites had higher On-time pill pick-up than outreach sites for adults (p<0.001) and pediatrics (p<0.001), and no difference between main and outreach sites for Retention in care for adults (p = 0.761) or pediatrics (p = 0.214). From 2012 to 2014 in adult sites, On-time pill pick-up (p = 0.001), Retention in care (p<0.001), and Pharmacy stock-outs (p = 0.002) worsened. In pediatric sites, On-time pill pick-up (p<0.001) and Pharmacy stock-outs (p = 0.012) worsened.

conclusionsResults of EWIs monitoring in Namibia provide evidence about ART programmatic functioning and contextualize results from national surveys of HIVDR. These results are worrisome as they show a decline in program performance over time. The national ART program is taking steps to minimize the emergence of HIVDR by strengthening adherence and retention of patients on ART, reducing stock-outs, and strengthening ART data quality.

Indexed as

AdolescentAdultAnti-Retroviral AgentsDrug Resistance, ViralFemaleHIVHIV InfectionsHumansMaleNamibiaViral LoadWorld Health OrganizationAnti-Retroviral Agents

Identifiers

PMID27906995
PMCPMC5132260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.